Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-29 May 2019 29 May 2019NewsHumanMedicines EMA closed 30-31 May 2019 28 May 2019NewsCorporate EMA facilitates early engagement with medicine developers to combat antimicrobial resistance 24 May 2019NewsHumanAntimicrobial resistance Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 21-22 May 2019 24 May 2019Press releaseVeterinaryMedicines Update of EU recommendations for 2019–2020 seasonal flu vaccine composition 20 May 2019NewsHumanVaccines Withdrawal of marketing authorisations for fenspiride medicines 17 May 2019Press releaseHumanMedicinesPharmacovigilance Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs 17 May 2019Press releaseHumanMedicinesPharmacovigilance Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2019 17 May 2019NewsHumanMedicinesPharmacovigilance European Medicines Agency closed 9 May 2019 7 May 2019News Working together for safe medicines in the EU 6 May 2019NewsHumanCorporatePharmacovigilance 1 … 99 100 101 102 103 Page 103 of 380 104 105 106 107 … 380
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-29 May 2019 29 May 2019NewsHumanMedicines
EMA facilitates early engagement with medicine developers to combat antimicrobial resistance 24 May 2019NewsHumanAntimicrobial resistance
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 21-22 May 2019 24 May 2019Press releaseVeterinaryMedicines
Update of EU recommendations for 2019–2020 seasonal flu vaccine composition 20 May 2019NewsHumanVaccines
Withdrawal of marketing authorisations for fenspiride medicines 17 May 2019Press releaseHumanMedicinesPharmacovigilance
Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs 17 May 2019Press releaseHumanMedicinesPharmacovigilance
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2019 17 May 2019NewsHumanMedicinesPharmacovigilance